February 13, 2025 - 03:57

Epicore Biosystems has successfully raised $26 million in funding aimed at scaling its innovative sweat-sensing wearable technology. This financial boost will allow the company to broaden its technological capabilities and explore new biomarker applications. The primary focus of this expansion is to improve real-time monitoring of hydration levels and metabolic health, providing users with valuable insights into their physiological states.
With the increasing demand for health and wellness solutions, Epicore's advancements in wearable technology are positioned to meet the needs of athletes and health-conscious individuals alike. By leveraging the latest in biosensor technology, the company aims to deliver precise and actionable data through its devices. This funding marks a significant milestone in Epicore's journey to revolutionize personal health monitoring, making it easier for users to track their hydration and metabolic conditions effectively. As the company moves forward, it is poised to make a substantial impact in the wearable tech market.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...